Back to Search
Start Over
Monitoring circulating prostate cancer cells by in vivo flow cytometry assesses androgen deprivation therapy on metastasis.
- Source :
- Cytometry. Part A; May2018, Vol. 93 Issue 5, p517-524, 8p
- Publication Year :
- 2018
-
Abstract
- Abstract: It remains controversial whether surgical castration prolongs survival rate and improves therapy prospects in patients suffering from prostate cancer. We used PC3 cell line to establish prostate tumor models. In vivo flow cytometry and ultrasonic imaging were used to monitor the process of prostate cancer growth, development and metastasis. We found out that the number of circulating tumor cells (CTCs) in orthotopic tumor model was higher than that in subcutaneous tumor model. The CTC number in orthotopic tumor model was due to burst growth, while CTC number in subcutaneous tumor model showed a gradual increase with tumor size. After androgen deprivation therapy (ADT) through testicular extraction, we constructed GFP‐PC3 subcutaneous tumor models and orthotopic tumor models. We found dramatically decreased CTC number, relieved symptoms caused by the tumor, and significantly prolonged survival time after testicular extraction in orthotopically transplanted prostate tumor model, while the carcinogenesis process and metastases were little influenced by ADT in subcutaneous tumor model. ADT treatment can restrict tumor growth, decrease the CTC number significantly and inhibit distant invasion through inhibition of tumor proliferation and tumor angiogenesis in orthotopical prostate tumor model. © 2018 International Society for Advancement of Cytometry [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15524922
- Volume :
- 93
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Cytometry. Part A
- Publication Type :
- Academic Journal
- Accession number :
- 130149108
- Full Text :
- https://doi.org/10.1002/cyto.a.23369